SSI Diagnostica Group’s attendance at the World Vaccine Congress Washington 2026
The World Vaccine Congress returned from 30 March – 2 April 2026 at the Walter E. Washington Convention Center, Washington, D.C. , uniting over 4,000 global vaccine leaders and 300+ exhibitors to highlight the newest advancements in vaccine research, analytics, development, and manufacturing.
We were excited to exhibit together with InDevR, now part of SSI Diagnostica Group, strengthening our leadership in pneumococcal vaccine QC testing with nextgeneration multiplexing assays and expanded customization capabiliies.
Capture a few impressions of the congress via our after show movie:
Recordings ouf our scientific talks
As a gold sponsor at this year’s World Vaccine Congress, SSI Diagnostica Group presented two expert-led talks. In case you were not able to attend, you can access the recordings of these talks below.
Talk 1 — Streamlining mRNA capping workflows
Streamlining process development of RNA capping using VaxArray 5’CapQ and HPLC-based methods.
Track: Immune profiling
Date: Wednesday, April 1
Time: 12:55–13:10
Location: Level 2, Room 207B
Speaker: Rebecca Young, PhD
Senior Scientist II at Aldevron, a Danaher Company
Talk 2 — Phenotyping in Vaccine Development
Seeing the whole picture: Why phenotyping is critical during vaccine development.
Track: Emerging & re‑emerging diseases
Date: Wednesday, April 1
Time: 15:10–15:25
Location: Level 2, Room 202A
Speaker: Pernille Elverdal, PhD
Sr. VP, Global Clinical Evidence and Medical Affairs
Full flexibility with one disease expert partner
Our portfolio covers Off-the-shelf and OEM products as well customizations.
Dengue virus, Pneumococccus, Influenza virus,
Salmonella, E.coli, C.difficile
Get in touch
If you have any questions, comments, or collaboration inquiries, you are very welcome to reach out.
Please fill in the form and we will get back to you as soon as possible.